Asymmetric syncytial expression of GLUT9 splice variants in human term placenta and alterations in diabetic pregnancies

Reproductive Sciences

Volumn 18, Issue 1, 2011, Pages 20-27

  Bibee, Kristin P ^a   Illsley, Nicholas P ^b   Moley, Kelle H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Basal membrane; Glucose transport; Maternal diabetes; Microvillus membrane; Syncytiotrophoblast

Indexed keywords

ANTIBODY; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 9A; GLUCOSE TRANSPORTER 9B; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ARTICLE; BASEMENT MEMBRANE; CELL FRACTIONATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; HUMAN; HUMAN TISSUE; INSULIN TREATMENT; MATERNAL DIABETES MELLITUS; MICROVILLUS; PATHOPHYSIOLOGY; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SYNCYTIOTROPHOBLAST;

BLOTTING, WESTERN; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROVILLI; PLACENTA; PREGNANCY; PREGNANCY IN DIABETICS; PROTEIN ISOFORMS; TROPHOBLASTS;

EID: 79952508984     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719110380276     Document Type: Article

References (35)

1. Barros LF, Yudilevich DL, Jarvis SM, Beaumont N, Baldwin SA. Quantitation and immunolocalization of glucose transporters in the human placenta. Placenta. 1995;16(7):623-633.
2. Jansson T, Wennergren M, Illsley NP. Glucose transporter protein expression in human placenta throughout gestation and in intrauterine growth retardation. J Clin Endocrinol Metab. 1993;77(6):1554-1562. (Pubitemid 24000913)
3. Takata K, Kasahara T, Kashahara M, Ezaki O, Hirano H. Localization of erythrocyte/HepG2-type glucose transporter (GLUT1) in human placental villi. Cell Tissue Res. 1992;267(3):407-412.
4. Hauguel-de Mouzon S, Challier JC, Kacemi A, Cauzac M, Malek A, Girard J. The GLUT3 glucose transporter isoform is differentially expressed within human placental cell types. J Clin Endocrinol Metab. 1997;82(8):2689-2694. (Pubitemid 27337895)
5. Xing AY, Challier JC, Lepercq J, et al. Unexpected expression of glucose transporter 4 in villous stromal cells of human placenta. J Clin Endocrinol Metab. 1998;83(11):4097-4101. (Pubitemid 28513602)
6. Gude NM, Stevenson JL, Rogers S, et al. GLUT12 expression in human placenta in first trimester and term. Placenta. 2003;24(5):566-570. (Pubitemid 37184779)
7. Scheepers A, Schmidt S, Manolescu A, et al. Characterization of the human SLC2A11 (GLUT11) gene: alternative promoter usage, function, expression, and subcellular distribution of three isoforms, and lack of mouse orthologue. Mol Membr Biol. 2005;22(4):339-351. (Pubitemid 41501236)
8. Gude NM, Stevenson JL, Murthi P, et al. Expression of GLUT12 in the fetal membranes of the human placenta. Placenta. 2005;26(1):67-72. (Pubitemid 40123678)
9. Augustin R, Carayannopoulos MO, Dowd LO, Phay JE, Moley JF, Moley KH. Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking. J Biol Chem. 2004;279(16):16229-16236. (Pubitemid 38509316)
10. Manolescu A, Augustin R, Moley KH, Cheeseman CI. A highly conserved hydrophobic motif in the exofacial vestibule of fructose transporting SLC2A proteins acts as a critical determinant of their substrate selectivity. Mol Membr Biol. 2007;24(5-6):1-9.
11. Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet Med. 2004;21(2):103-113. (Pubitemid 38221808)
12. Vohr BR, McGarvey ST, Tucker R. Effects of maternal gestational diabetes on offspring adiposity at 4-7 years of age. Diabetes Care. 1999;22(8):1284-1291. (Pubitemid 29350238)
13. Lindsay RS, Dabelea D, Roumain J, Hanson RL, Bennett PH, Knowler WC. Type 2 diabetes and low birth weight: the role of paternal inheritance in the association of low birth weight and diabetes. Diabetes. 2000;49(3):445-449. (Pubitemid 30131791)
14. Silverman BL, Rizzo TA, Cho NH, Metzger BE. Long-term effects of the intrauterine environment. The Northwestern University Diabetes in Pregnancy Center. Diabetes Care. 1998;21(suppl 2):B142-B149.
15. Gaither K, Quraishi AN, Illsley NP. Diabetes alters the expression and activity of the human placental GLUT1 glucose transporter. J Clin Endocrinol Metab. 1999;84(2):695-701. (Pubitemid 29075708)
16. Carayannopoulos MO, Schlein A, Wyman A, Chi M, Keembiyehetty C, Moley KH. GLUT9 is differentially expressed and targeted in the preimplantation embryo. Endocrinology. 2004;145(3):1435-1443. (Pubitemid 38281029)
17. Evans SA, Doblado M, Chi MM, Corbett JA, Moley KH. Facilitative glucose transporter 9 expression affects glucose sensing in pancreatic beta-cells. Endocrinology. 2009;150(12):5302-5310.
18. Kim ST, Moley KH. The expression of GLUT8, GLUT9a, and GLUT9b in the mouse testis and sperm. Reprod Sci. 2007;14(5):445-455.
19. Kim ST, Moley KH. Regulation of facilitative glucose transporters and AKT/MAPK/PRKAA signaling via estradiol and progesterone in the mouse uterine epithelium. Biol Reprod. 2009;81(1):188-198.
20. Jansson T, Powell TL, Illsley NP. Non-electrolyte solute permeabilities of human placental microvillous and basal membranes. J Physiol. 1993;468:261-274. (Pubitemid 23254444)
21. Baumann MU, Deborde S, Illsley NP. Placental glucose transfer and fetal growth. Endocrine. 2002;19(1):13-22. (Pubitemid 36106249)
22. Jansson T, Wennergren M, Powell TL. Placental glucose transport and GLUT 1 expression in insulin-dependent diabetes. Am J Obstet Gynecol. 1999;180(1 pt 1):163-168. (Pubitemid 29088409)
23. Keembiyehetty C, Augustin R, Carayannopoulos MO, et al. Mouse glucose transporter 9 splice variants are expressed in adult liver and kidney and are up-regulated in diabetes. Mol Endocrinol. 2006;20(3):686-697. (Pubitemid 43291218)
24. Hagerman DD, Villee CA. The transport of fructose by human placenta. J Clin Invest. 1952;31(10):911-913.
25. Bertolini M, Wallace C, Anderson G. Expression profile and protein levels of placental products as indirect measures of placental function in in vitro-derived bovine pregnancies. Reproduction. 2006;131(1):163-173. (Pubitemid 43230713)
26. Rand EB, Depaoli AM, Davidson NO, Bell GI, Burant CF. Sequence, tissue distribution, and functional characterization of the rat fructose transporter GLUT5. Am J Physiol. 1993;264(6 pt 1):G1169-G1176. (Pubitemid 23196823)
27. Kawasaki T, Akanuma H, Yamanouchi T. Increased fructose concentrations in blood and urine in patients with diabetes. Diabetes Care. 2002;25(2):353-357. (Pubitemid 41079635)
28. Meznarich HK, Hay WW Jr, Sparks JW, Meschia G, Battaglia FC. Fructose Disposal and oxidation rates in the ovine fetus. Exp Physiol. 1987;72(4):617-625.
29. Pere MC. Maternal and fetal blood levels of glucose, lactate, fructose and insulin in the conscious pig. J Anim Sci. 1995;73(10):2994-2999.
30. Morris ED, Wood C, Archer GD. The effect on cord blood glucose levels of the intravenous administsration of fructose to the mother. J Obstet Gynecol Br Commonw. 1964;71:766-767.
31. Thorburn AW, Storlien LH, Jenkins AB, Khouri S, Kraegen EW. Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr. 1989;49(6):1155-1163. (Pubitemid 19169675)
32. Lee MK, Miles PD, Khoursheed M, Gao KM, Moossa AR, Olefsky JM. Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes. 1994;43(12):1435-1439.
33. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615-1625. (Pubitemid 40770750)
34. Delbosc S, Paizanis E, Magous R, et al. Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis. 2005;179(1):43-49. (Pubitemid 40249784)
35. Zhao W, Devamanoharan PS, Varma SD. Fructose induced deactivation of antioxidant enzymes: preventive effect of pyruvate. Free Radic Res. 2000;33(1):23-30. (Pubitemid 30349980)